Lyme disease Adaptive Biotechnologies Making Inroads in MRD, Immune Medicine Businesses Premium The Seattle-based company recently completed a strategic reorganization around its two major business areas by cutting the workforce and appointing a new CFO. Adaptive Biotechnologies to Focus on Immune Medicine, Minimal Residual Disease Testing Businesses Premium The Seattle-based company said this week that its immune medicine and minimal residual disease testing business arms will drive the firm's future growth. Adaptive Biotechnologies' T-Cell Assay Plans Boosted by Medicare Nod for COVID Test Premium The company has slightly extended its timeline for launching a Lyme disease test to focus on marketing its COVID assay for immunocompromised individuals. Adaptive Biotech Touts Progress Toward Lyme and Gastrointestinal Disease Diagnostics Premium The firm is expanding its plans from a Crohn's disease test to a broader GI differential diagnostic and continues to expect to launch its Lyme disease assay by year-end. UK Researchers Publish Data on qPCR-Based Early-Stage Lyme Disease Test Premium The test relies on using quantitative PCR to target genes encoded by prophages — viruses present in Lyme-causing bacteria, which can be easier to detect than the bacteria itself. Nov 11, 2020 Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test Premium Jul 16, 2020 NIH Grants HelixBind $3M for Early Detection Lyme Test May 13, 2020 Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19 Premium Feb 27, 2020 Adaptive Biotechnologies ImmunoSeq Dx Development Jolts Forward With Lyme Disease in Crosshairs Premium Sep 20, 2019 Roche Gains FDA Clearance for Cobas Babesia Blood Test Aug 14, 2019 Adaptive Biotechnologies Plans New Product Launches, Expanded FDA Label for ClonoSeq Premium Dec 11, 2018 ChromaCode Tackling Tick-Borne Illness Testing With Multiplex Molecular Panel Premium Nov 21, 2018 Institute for Systems Biology Using NIH Grant to Develop Peptide Dx for Lyme Disease Premium Jul 13, 2018 Citizen Science Project Helps Determine Distribution of Tick Pathogens in US Aug 28, 2017 Lyme Disease History, Future Explored With North American Borrelia Genome Set Aug 17, 2017 Mass Spec Test Developed to Distinguish Lyme Disease From Similar Condition May 2, 2017 T2 Biosystems' Gain in Q1 Product Sales Offset by Decline in Research Revenue Mar 8, 2017 TGen LymeSeq Assay Moving Forward With Financial Backing From Advocacy Group Premium Feb 13, 2017 T2 Biosystems Q4 Revenues Fall 10 Percent Feb 13, 2017 Ceres Nanosciences Raises $3M in Series A Funding Jan 13, 2017 Wearable Sensors May Predict Early Onset of Illness, Study Says Sep 23, 2016 Canon's $40M Cash Infusion Bolsters T2 Biosystems' Cash Position, Product Development Efforts Premium Jun 24, 2016 Oxford Immunotec to Acquire Imugen for $22.2M, Enter Tick-Borne Disease Market Mar 18, 2016 Genetic Search Uncovers Multiple Pathogens in Many Individual Ticks Feb 12, 2016 UCSF-led Team IDs Blood Expression Signature in Individuals With Acute Lyme Disease Load More Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.